Helixara RetaCode Rx (Retatrutide)
40mg
Retatrutide (40 mg) is an investigational incretin-based compound studied for its effects on metabolic pathways and appetite/energy regulation.
Retatrutide (LY3437943) is an investigational, synthetic peptide designed as a tri-agonist at the GIP, GLP-1, and glucagon receptors. It is studied for combined effects on metabolic signaling, including pathways related to glucose regulation, appetite/satiety signaling, and energy-balance mechanisms. (PubMed) Common research applications include receptor pharmacology, assay development/validation, and comparative studies of multi-receptor incretin–glucagon signaling. (PubMed)
Top 3 effects (reported in studies):
- Weight loss: large, dose-dependent reductions in body weight. (New England Journal of Medicine)
- Improved glycemic control (in T2D studies): reductions in HbA1c and other glycemic measures vs comparators/placebo.
- Cardiometabolic improvements: reductions in blood pressure and atherogenic lipids (e.g., triglycerides, non-HDL cholesterol); liver-fat reduction has also been reported in steatotic liver disease research. (ScienceDirect)
Top 3 mechanism components (how it works):
- GLP-1 receptor agonism: increases satiety, slows gastric emptying, and enhances glucose-dependent insulin secretion.
- GIP receptor agonism: adds incretin signaling that can synergize with GLP-1 effects on insulin/glucose regulation and appetite pathways.
- Glucagon receptor agonism: contributes to higher energy expenditure (shown strongly in preclinical work) and may add hepatic metabolic effects—helping explain broader metabolic outcomes beyond appetite alone.
For research use only.
You may also be interested in
Helixara NAD+ 500mg/3mL dual-chamber
500mg
NAD+ dual-chamber 500mg pen
CagriCode Rx (Cagrilintide)
20mg
40mg
Cagrilintide (AM833) is an investigational, once-weekly injectable amylin analogue that activates amylin/calcitonin receptors to increase satiety and reduce food intake
Helixara Selank 10 mg
10mg
20mg
It is commonly evaluated in research models related to stress response, anxiety-like behavior, cognitive performance, and central nervous system regulation.
Helixara Eterna C³ — NAD⁺ + Methylene Blue + Resveratrol System
1030 mg (500+30+500)
NAD⁺ (500 mg), Methylene Blue (30 mg), and Resveratrol (500 mg)
Helixara ReCode N² — Epitalon + MNM
310 mg (1+300)
Support studies on cellular longevity, mitochondrial activation, and circadian regulation
Helixara TirzeCode rx40 | rx60
40 mg
60 mg
High-purity Tirzepatide (40 mg) in sterile research-grade format
Helixara Éclat C3 Gluthatione +Vit.C + GHK-Cu Peptide
Glutathione 1000mg +Vit.C 1000mg + GHK-Cu Peptide 100mg
Glutathione (1000 mg), Vitamin C (1000 mg), and GHK-Cu Peptide (100mg)
NAD+ 1000 mg Lyophilized Powder + 10 ml Bacteriostatic Water (2-Vial Research Kit)
1000 mg + 10 ml
Sterile research-use set with one vial of lyophilized NAD+ and one vial of bacteriostatic water for reconstitution. For research purposes only.
Helixara MOTS-c — Research Peptide
20 mg
High-purity MOTS-c peptide (20 mg) in sterile cartridge +injection pen format, studied in relation to metabolic signaling and mitochondrial pathways.
Helixara RetaCode
20 mg
40 mg
60 mg
Research-grade Retatrutide (20 mg) in sterile cartridge + injection pen format.